Citations for
1MAFD17, SLC22A16
Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus.
Fan J, Ionita-Laza I, McQueen MB, Devlin B, Purcell S, Faraone SV, Allen MH, Bowden CL, Calabrese JR, Fossey MD, Friedman ES, Gyulai L, Hauser P, Ketter TB, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel JK, Sachs GS, Thase ME, Molay FB, Escamilla MA, Nimgaonkar VL, Sklar P, Laird NM, Smoller JW.
Am J Med Genet B Neuropsychiatr Genet 153B(1):29-37. 2010
2SLC22A16
The human carnitine transporter SLC22A16 mediates high affinity uptake of the anticancer polyamine analogue bleomycin-A5.
Aouida M, Poulin R, Ramotar D.
J Biol Chem 285(9):6275-84. Epub 2009 Dec 25.PMID: 20037140 2010
3SLC22A16
Expression of organic cation transporter SLC22A16 in human endometria.
Sato N, Ito K, Onogawa T, Akahira J, Unno M, Abe T, Niikura H, Yaegashi N.
Int J Gynecol Pathol 26(1):53-60. 2007
4SLC22A16
Characterization of the organic cation transporter SLC22A16: a doxorubicin importer.
Okabe M, Unno M, Harigae H, Kaku M, Okitsu Y, Sasaki T, Mizoi T, Shiiba K, Takanaga H, Terasaki T, Matsuno S, Sasaki I, Ito S, Abe T.
Biochem Biophys Res Commun 333(3):754-62. 2005
5SLC22A15, SLC22A16
Novel human cDNAs homologous to Drosophila Orct and mammalian carnitine transporters.
Eraly SA, Nigam SK.
Biochem Biophys Res Commun 297(5):1159-66. 2002
6SLC22A16
Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition.
Enomoto A, Wempe MF, Tsuchida H, Shin HJ, Cha SH, Anzai N, Goto A, SakamotoA, Niwa T, Kanai Y, Anders MW, Endou H.
J Biol Chem 277(39):36262-71. Epub 2002 Jun 27. 2002
7SLC22A16
Identification of OCT6 as a novel organic cation transporter preferentially expressed in hematopoietic cells and leukemias.
Gong S, Lu X, Xu Y, Swiderski CF, Jordan CT, Moscow JA.
Exp Hematol 30(10):1162-9. 2002